User Safety: safe
Also Read
- AbbVie Announces Phase 3 AFFIRM Trial Data: Skyrizi Achieves 35.8% Endoscopic Remission in Crohn’s Disease
- Army Establishes Futures and Autonomy Command to Accelerate Unmanned Systems Integration
- Independent Regulator Vows Resignation Over Political Interference in Manchester City Case
- Zelensky Warns of Russian Missile Strike on Kyiv Power Plant Without Allied Warning

